|
Refractory testicular pure seminoma (PS) and non-seminomatous(NS) germ cell tumors (GCT): A comprehensive genomic profiling (CGP) study. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Foundation Medicine |
| |
|
No Relationships to Disclose |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - foundation medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine; Foundation Medicine |
Stock and Other Ownership Interests - Agios; Blueprint Medicines; Exelixis |
Patents, Royalties, Other Intellectual Property - patents via FOundation Medicine; Patents via Seres Health on microbiome stuff in non neoplastic disease (I) |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Leadership - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
Patents, Royalties, Other Intellectual Property - Receive periodic royalties related to T790M patent awarded to Memorial Sloan Kettering Cancer Center |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine; Gilead Sciences |
| |
|
No Relationships to Disclose |
| |
|
Employment - Foundation Medicine |
Stock and Other Ownership Interests - Foundation Medicine |